ArticleEJHaem2025

Early Free Light-Chain Suppression as a Prognostic Marker in Relapsed and Refractory Myeloma Patients Treated With BCMA-Directed CAR-T Cells.

Tim Richardson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.